Literature DB >> 2772495

Recurrence of nasal polyps after surgical treatment.

S Jäntti-Alanko1, E Holopainen, H Malmberg.   

Abstract

Recurrence of nasal polyposis after polypectomy or ethmoidectomy was studied in 85 patients four years after surgery. The patients were classified into one of three groups according to clinical findings: an atopy group (history confirmed by skin test or nasal provocation), an acetylsalicylic acid intolerance (ASA) group (confirmed by provocation), or an "intrinsic" group (no specific diagnosis). The risk of recurrence was significantly greater in patients with ASA intolerance than in the other two patient groups; the frequency of reoperations during the follow-up period was significantly higher in the ASA group and the need for topical corticosteroid treatment had also been more frequent. Bronchial asthma was diagnosed in 40% of all patients. Asthma was significantly more often associated with ASA group (91%) vs 46% at AT and in only 16% at INTR group.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2772495

Source DB:  PubMed          Journal:  Rhinol Suppl        ISSN: 1013-0047


  11 in total

1.  The aspirin disease.

Authors:  D Schiavino; E Nucera; A Milani; M Del Ninno; A Buonomo; J Sun; G Patriarca
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

Review 2.  Rhinosinusitis and nasal polyposis in aspirin sensitive and aspirin tolerant patients: are they different?

Authors:  M L Kowalski
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

3.  Aspirin desensitization: useful treatment for chronic rhinosinusitis with nasal polyps (CRSwNP) in aspirin-exacerbated respiratory disease (AERD)?

Authors:  Ludger Klimek; Ralph Dollner; Oliver Pfaar; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2014-06       Impact factor: 4.806

4.  [Rhinosinusitis guidelines of the German Society for Otorhinolaryngology, Head and Neck Surgery].

Authors:  B A Stuck; C Bachert; P Federspil; W Hosemann; L Klimek; R Mösges; O Pfaar; C Rudack; H Sitter; M Wagenmann; K Hörmann
Journal:  HNO       Date:  2007-10       Impact factor: 1.284

5.  Effects of lysine-acetylsalicylate (LAS) treatment in nasal polyposis: two controlled long term prospective follow up studies.

Authors:  E Nucera; D Schiavino; A Milani; M Del Ninno; C Misuraca; A Buonomo; C D'Ambrosio; G Paludetti; G Patriarca
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

6.  Sinonasal outcome under aspirin desensitization following functional endoscopic sinus surgery in patients with aspirin triad.

Authors:  Miriam Havel; Lena Ertl; Franziska Braunschweig; Sabine Markmann; Andreas Leunig; Fernando Gamarra; Matthias F Kramer
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-05-18       Impact factor: 2.503

7.  Prostaglandin E2 resistance in granulocytes from patients with aspirin-exacerbated respiratory disease.

Authors:  Tanya M Laidlaw; Anya J Cutler; Molly S Kidder; Tao Liu; Juan Carlos Cardet; Heng Chhay; Chunli Feng; Joshua A Boyce
Journal:  J Allergy Clin Immunol       Date:  2014-01-31       Impact factor: 10.793

Review 8.  Pathogenesis of nasal polyps: an update.

Authors:  Rafal Pawliczak; Anna Lewandowska-Polak; Marek L Kowalski
Journal:  Curr Allergy Asthma Rep       Date:  2005-11       Impact factor: 4.919

9.  Factors Affecting the Control of Chronic Rhinosinusitis With Nasal Polyps: A Comparison in Patients With or Without NERD.

Authors:  Markus Jukka Lilja; Anni Koskinen; Paula Virkkula; Seija Inkeri Vento; Jyri Myller; Sari Hammarén-Malmi; Anu Laulajainen-Hongisto; Maija Hytönen; Antti Mäkitie; Jura Numminen; Saara Sillanpää; Hannu Raitiola; Markus Rautiainen; Sanna Katriina Toppila-Salmi
Journal:  Allergy Rhinol (Providence)       Date:  2021-04-26

10.  Factors affecting revision rate of chronic rhinosinusitis.

Authors:  Anni Koskinen; Riikka Salo; Heini Huhtala; Jyri Myller; Markus Rautiainen; Janne Kääriäinen; Matti Penttilä; Risto Renkonen; Hannu Raitiola; Mika Mäkelä; Sanna Toppila-Salmi
Journal:  Laryngoscope Investig Otolaryngol       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.